An emerging approach for care and regenerative therapy of chronic wounds, which have an increased incidence in elderly, diabetics, immuno-suppressed and immobilised people, uses smart hydrogels for a spatio-temporally triggerred repair process. Hyaluronic acid (HyA)-based dressings are already safely used, e.g., in treating diabetic foot ulcer.
The novel multifunctional HyA-CAR(GHK)-Cu dressing, deposited via an atmospheric plasma technology ad hoc designed and developed, starts from HyA conjugated with a dipeptide (carnosine, CAR) and/or a tripeptide (GHK), exhibiting inhibitory effects against carnosinase as well as antioxidant and anti-inflammatory properties. The scaffold is further implemented by the incorporation of copper, which has angiogenic and antibacterial properties, as well as SOD-like activity in the CAR-Cu and GHK-Cu complexes. The HyA-CAR(GHK)-Cu hydrogels will provide a novel unique synergic activity in the modulation of the wound healing and scar repair actions.
The consortium includes 2 manufacturers which are FIDIA (suppliers of advance wound care devices) and IONICS, and also 2 universities (ULB and UNICT).
More specificly the role of IONICS is to provide his support to scale up the laboratory equipment designed by the ULB-CHANI team to a pilot system able to carry out a pre-serie production.
The project started on January 2019 for a 36 month-period.
If you need more information, please contact Fabian RENAUX : info@ionics-group.com.
Project Partners:
FIDIA, ULB, UNICT and IONICS
The project is co-financed by the Walloon Research Administration, DGO6.
